Dementia with Lewy Bodies (DLB) is a common form of cognitive neurodegenerative
disease. Only one third of patients are correctly diagnosed due to the clinical similarity …

Abstract Dementia with Lewy Bodies (DLB) is the second most common form of dementia
after Alzheimer's disease (AD), accounting for 15% to 20% of neuropathologically defined …

The detection of α-synuclein (α-syn) in the cerebrospinal fluid (CSF) of patients with
synucleinopathy has yielded promising but inconclusive results. The aim of the present …

Background Dementia with Lewy bodies (DLB) shares common clinical, neuropsychological
and pathological features with other dementia subtypes, such as Alzheimer's disease (AD) …

Dementia with Lewy bodies is a progressive neurodegenerative disorder, clinically
characterized by gradual cognitive impairment and fluctuating cognition, behavioral …

Background: The clinical diagnostic criteria for dementia with Lewy bodies (DLB) have a low
sensitivity, and there are no generally accepted biomarkers to distinguish DLB from other …

Background: Dementia with Lewy bodies (DLB) is difficult to differentiate from other neuro-
degenerative diseases. Patients are often mistaken to suffer from Parkinson's disease (PD) …

Background Several studies have investigated the value of alpha-synuclein assay in the
cerebrospinal fluid (CSF) of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) …

Background: Dementia with Lewy bodies (DLB) accounts for 15–20% of the millions of
people worldwide with dementia. Accurate diagnosis is essential to avoid harm and optimize …

Background/Aims: Detection and differentiation of neurodegenerative dementias, such as
dementia with Lewy bodies (DLB) and Alzheimer's disease (AD), with blood-based …